• Yung-An Jang, Hsiao-Yu Wu, Ya-Ting Hsu, Yi-Kai Chen, Hung-Yi Chiou, Huey-Kang Sytwu, Wei J Chen, and Hsiao-Hui Tsou.
• Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.
• Prev Med. 2024 Jan 1; 178: 107820107820.

ObjectiveAlthough the World Health Organization and many governments have recategorized COVID-19 as a generally mild to moderately severe disease, consecutive pandemic waves driven by immune escape variants have underscored the need for timely and accurate prediction of the next outbreak. Nevertheless, little attention has been paid to translating genomic data and infection- and vaccine-induced immunity into direct estimates.MethodsWe retrieved epidemiologic and genomic data shortly before pandemic waves across 14 developed countries from late 2021 to mid-2022 and examined associations between early-stage variant competition, infection- and vaccine-induced immunity, and the time intervals between wave peaks. We applied regression analysis and the generalized estimating equation method to construct an inferential model.ResultsEach per cent increase in the proportion of a new variant was associated with a 1.0% reduction in interpeak intervals on average. Curvilinear associations between vaccine-induced immunity and outcome variables were observed, suggesting that reaching a critical vaccine distribution rate may decrease the caseload of the upcoming wave.ConclusionsBy leveraging readily accessible pre-outbreak genomic and epidemiologic data, our results not only substantiate the predictive potential of early variant fractions but also propose that immunity acquired through infection alone may not sufficiently mitigate transmission. Conversely, a rapid and widespread vaccination initiative appears to be correlated with a decrease in disease incidence.Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

10 keywords...

hide…